K230814

Substantially Equivalent

VRNT

Applicant: Cognifisense, Inc.
Product code: QRA
Advisory panel: Neurology
Date received: 2023-03-24
Decision date: 2023-10-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sunnyvale, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.